ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,876Medicare Part D Prescriptions Filled, Including Refills

Rank: 157 out of 910

$678K Total Retail Price of All Prescriptions

Rank: 82 out of 910

520 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

28% of this provider’s 520 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

22% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 5,442 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
OXYCODONE HCL 418 90 S2 1 42
LISINOPRIL 396 315 2 2
HYDROCODONE-ACETAMINOPHEN 381 214 S3 3 8
SIMVASTATIN 324 239 4 3
METFORMIN HCL 258 182 5 6
AMLODIPINE BESYLATE 193 155 6 4
OMEPRAZOLE 173 126 7 5
LEVOTHYROXINE SODIUM 169 125 8 1
GABAPENTIN 153 75 9 13
METOPROLOL TARTRATE 129 94 10 7
FUROSEMIDE 120 80 11 9
HYDROCHLOROTHIAZIDE 111 89 12 12
WARFARIN SODIUM 111 77 12 11
CYCLOBENZAPRINE HCL 110 32 R 14 80
MORPHINE SULFATE ER 107 24 S2 15 52
CITALOPRAM HBR 106 65 16 19
OXYCODONE-ACETAMINOPHEN 104 60 S2 17 31
ZOLPIDEM TARTRATE 103 65 18 17
RANITIDINE HCL 95 51 19 28
TAMSULOSIN HCL 93 88 20 29
PROAIR HFA 91 62 21 40
DIOVAN 86 82 22 34
METHADONE HCL 81 13 S2 23 143
NAPROXEN 72 11 24 96
ATORVASTATIN CALCIUM 66 48 25 14
ALENDRONATE SODIUM 66 63 25 22
ROPINIROLE HCL 65 55 27 119
CYMBALTA 65 39 27 58
PEN NEEDLE 62 46 29 124
ATENOLOL 61 37 30 10
INSULIN SYRINGE 60 45 31 47
FLUOXETINE HCL 59 21 32 49
AZITHROMYCIN 58 34 33 41
GLIPIZIDE 58 45 33 38
HUMALOG 57 23 35 128
LANTUS 57 38 35 30
FENTANYL 56 12 S2 37 142
LANTUS SOLOSTAR 53 43 38 112
KLOR-CON M20 53 27 38 95
OXYCONTIN 53 0 S2 38 126
PROMETHAZINE HCL 52 28 R 41 129
CEPHALEXIN 51 33 42 90
NAMENDA 51 51 42 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.